Clorox (CLX) Common Equity (2009 - 2026)

Clorox has reported Common Equity for 18 years, with the latest figure at $252.0 million in Q2 2026.

• On a quarterly basis, Common Equity fell 47.72% year-over-year to $252.0 million in Q2 2026; TTM through Jun 2026 was $252.0 million, a 47.72% decrease from a year earlier, with the FY2026 full-year figure at $252.0 million, down 47.72% from the prior year.
• Common Equity was $252.0 million for Q2 2026 at Clorox, up from $92.0 million in the prior quarter.
• The five-year high for Common Equity was $729.0 million in Q2 2022, with the low at $35.0 million in Q4 2025.
• Average Common Equity over 5 years is $304.6 million, with a median of $238.0 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Common Equity tumbled 73.59% in 2023, then jumped 70.99% in 2024.
• Over 5 years, Common Equity stood at $491.0 million in 2022, then tumbled by 55.6% to $218.0 million in 2023, then plunged by 44.5% to $121.0 million in 2024, then tumbled by 71.07% to $35.0 million in 2025, then surged by 620.0% to $252.0 million in 2026.
• The last three Common Equity figures came in at $252.0 million (Q2 2026), $92.0 million (Q1 2026), and $35.0 million (Q4 2025), per Business Quant data.